Skip to main content
Clinical Trials/NCT07006454
NCT07006454RecruitingNot Applicable

Comparison of Ventro-Cephalic to Dorso-Caudal Translatoric Glides in Management of Cervicogenic Headache

Foundation University Islamabad1 site in 1 country40 target enrollmentStarted: July 18, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
40
Locations
1
Primary Endpoint
Headache intensity

Study Overview

Brief Summary

This study is a randomised control trial and the purpose of this study is to compare ventro-cephalic to dorso-caudal translatoric glides in management of cervicogenic headache.

Detailed Description

Participants will be recruited into their respective groups using a coin toss method.Cervicogenic headache will be assesed using International Classification of Headache Disorders, 3rd edition:

A- Any headache fulling criterion C. B- Clinical and/or imaging evidence of lesion or disorder in cervical spine or soft tissues of neck that can cause headache.

C- Evidence of cause of headache demonstrated by at least 2 of these:

  1. headache has developed in temporal relation to the onset of the cervical disorder or lesion.
  2. headache has significantly improved or resolved in parallel with improvement in cervical lesion or disorder.
  3. cervical range of motion is reduced, and headache is made significantly worse by provocative maneuvers.
  4. headache is abolished following anaesthetic blocked of cervical structure. D- Not better accounted for by another ICHD-3 diagnosis.

CEH subject selection is based on clinical criteria, however anaesthetic blockades is not used as a criterion.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 44 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •• Age 18 to 44 years old
  • •Both male and female A- Any headache fulling criterion C. B- Clinical and/or imaging evidence of lesion or disorder in cervical spine or soft tissues of neck that can cause headache.
  • •C- Evidence of cause of headache demonstrated by at least 2 of these:
  • •headache has developed in temporal relation to the onset of the cervical disorder or lesion.
  • •headache has significantly improved or resolved in parallel with improvement in cervical lesion or disorder.
  • •cervical range of motion is reduced, and headache is made significantly worse by provocative maneuvers.
  • •headache is abolished following diagnostic blocked of cervical structure. D- Not better accounted for by another ICHD-3 diagnosis

Exclusion Criteria

  • •1- Tension-type headaches and migraine 2- History of Vertigo or Dizziness 3- Already taking manual therapy treatment 4- Prior surgery to the head and neck 5- Trauma

Arms & Interventions

Group A

Experimental

Participants of group A will receive ventro-cephalic translatoric glide, total of 3 sets with 15 repetitions per set.

Duration (5 treatment sessions per week for 2 weeks)

Intervention: Ventro-Cephalic Translatoric Glide (Procedure)

Group B

Experimental

Participants of group B will receive Dorso-caudal translatoric glide, total of 3 sets with 15 repetitions per set.

Duration (5 treatment sessions per week for 2 weeks)

Intervention: Dorso-Caudal Translatoric Glide (Procedure)

Outcomes

Primary Outcomes

Headache intensity

Time Frame: Variable will be evaluated at baseline and then weekly for next 2 weeks.

It will be measured on a numeric pain rating scale where participant select number ranging from 0 to 10 based on pain intensity, with 0 representing no pain and 10 denotes extreme pain.

Headache disability

Time Frame: Variable will be evaluated at baseline and then weekly for next 2 weeks

It will be measured using headache disability index (HDI) which is a 25 item self-rated questionnaire in which participants rate their headache disability by selecting an option from 1 to 3 (yes= 4 points, sometimes= 2 points, and No = 0 point) then sum of responses is used to get final score. Interpretation: 10 to 28= mild disability 30 to 48= moderate disability 50 to 68= severe disability 72 or more= complete disability

Quality of Life of patient

Time Frame: Variable will be evaluated at baseline and then weekly for next 2 weeks

It will be measured using headache impact test (HIT-6), this tool is used to measure impact of headache on ability to function, a 6 items self-rated questionnaire in which participant select an option from 1 to 5 (Never= 6 points, rarely= 8, sometimes= 10, very often= 11, always= 13) then sum of responses is used to get final score. Interpretation: 60 or more= Very severe impact 56 to 59= Substantial impact 50 to 55= Some impact 49 or less= Little or no impact

Headache Frequency

Time Frame: Variable will be evaluated at baseline and then weekly for next 2 weeks

It will be measured using medical diary, which is a self-reported measure in which the patient will be asked to report the number of headache days per week through a medical logbook, which will be recorded every day and night.

Cervical range of motion

Time Frame: Variable will be evaluated at baseline and then weekly for next 2 weeks

It will be measured using CROM instrument a plastic frame device that is fastened to the head with help of Velcro-strap, it consist of 3 separate inclinometers that are fixed to frame (1 in sagittal plan which evaluates range of motion in flexion and extension, where 2nd in frontal plane which evaluates range of motion in side bending, and 3rd in horizontal plan which indicates range of motion in rotation)

Cervical flexion rotation test

Time Frame: Variable will be evaluated at baseline and then weekly for next 2 weeks

It is used to evaluate impairment of cervical function as the diagnostic criterion of internation headache society (IHS) consist of subjective feathers which includes impairments at atlanto-axial motion segments which is assessed by cervical flexion rotation test.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials